N-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-N-phenylmethoxybenzamide

C25H34N2O4Si — CID 127034444

IUPACN-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-N-phenylmethoxybenzamide
SMILESC[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]1C(=O)N[C@@H]1N(OCc1ccccc1)C(=O)c1ccccc1
InChIInChI=1S/C25H34N2O4Si/c1-18(31-32(5,6)25(2,3)4)21-22(26-23(21)28)27(24(29)20-15-11-8-12-16-20)30-17-19-13-9-7-10-14-19/h7-16,18,21-22H,17H2,1-6H3,(H,26,28)/t18-,21-,22-/m1/s1
InChIKeyDKWRGFMPVDRQDF-STZQEDGTSA-N
MW454.64 g/mol
LogP4.74
Rot. Bonds8

About N-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-N-phenylmethoxybenzamide

N-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-N-phenylmethoxybenzamide (PubChem CID 127034444) has the molecular formula C25H34N2O4Si and a molecular weight of 454.64 g/mol. Its IUPAC name is N-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-N-phenylmethoxybenzamide.

Molecular Properties

Compound NameN-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-N-phenylmethoxybenzamide
PubChem CID127034444
Molecular FormulaC25H34N2O4Si
Molecular Weight454.64 g/mol
Exact Mass454.23
IUPAC NameN-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-N-phenylmethoxybenzamide
SMILESC[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]1C(=O)N[C@@H]1N(OCc1ccccc1)C(=O)c1ccccc1
InChIInChI=1S/C25H34N2O4Si/c1-18(31-32(5,6)25(2,3)4)21-22(26-23(21)28)27(24(29)20-15-11-8-12-16-20)30-17-19-13-9-7-10-14-19/h7-16,18,21-22H,17H2,1-6H3,(H,26,28)/t18-,21-,22-/m1/s1
InChIKeyDKWRGFMPVDRQDF-STZQEDGTSA-N
XLogP4.74
TPSA67.87 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds8
Heavy Atoms32
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500454.64
LogP ≤ 54.74
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze N-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-N-phenylmethoxybenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-N-phenylmethoxybenzamide?
The IUPAC name of N-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-N-phenylmethoxybenzamide (CID 127034444) is N-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-N-phenylmethoxybenzamide.
What is the SMILES notation for N-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-N-phenylmethoxybenzamide?
The canonical SMILES for N-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-N-phenylmethoxybenzamide is C[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]1C(=O)N[C@@H]1N(OCc1ccccc1)C(=O)c1ccccc1.
What is the InChIKey of N-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-N-phenylmethoxybenzamide?
The InChIKey is DKWRGFMPVDRQDF-STZQEDGTSA-N. The full InChI is InChI=1S/C25H34N2O4Si/c1-18(31-32(5,6)25(2,3)4)21-22(26-23(21)28)27(24(29)20-15-11-8-12-16-20)30-17-19-13-9-7-10-14-19/h7-16,18,21-22H,17H2,1-6H3,(H,26,28)/t18-,21-,22-/m1/s1.
What are the key properties of N-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-N-phenylmethoxybenzamide?
N-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-N-phenylmethoxybenzamide has a molecular weight of 454.64 g/mol, XLogP of 4.74, 8 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]-N-phenylmethoxybenzamide is sourced from PubChem (CID 127034444), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).